Search hospitals > Texas > San Antonio
Cancer Therapy and Research Center
Claim this profileSan Antonio, Texas 78229
Global Leader in Solid Tumors
Global Leader in Cancer
Conducts research for Breast Cancer
Conducts research for Lung Cancer
Conducts research for Lymphoma
175 reported clinical trials
9 medical researchers
Summary
Cancer Therapy and Research Center is a medical facility located in San Antonio, Texas. This center is recognized for care of Solid Tumors, Cancer, Breast Cancer, Lung Cancer, Lymphoma and other specialties. Cancer Therapy and Research Center is involved with conducting 175 clinical trials across 222 conditions. There are 9 research doctors associated with this hospital, such as Virginia G. Kaklamani, John Sarantopoulos, MD, Daruka Mahadevan, MD, PhD, and Andrew Brenner, MD, PhD.Area of expertise
1Solid Tumors
Global LeaderStage IV
Stage III
PD-L1 positive
2Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
Top PIs
Virginia G. KaklamaniUniversity of Texas Health Science Center at San Antonio8 years of reported clinical research
Expert in Breast Cancer
Studies Breast cancer
14 reported clinical trials
47 drugs studied
John Sarantopoulos, MDUniversity of Texas Health Science Center at San Antonio7 years of reported clinical research
Studies Cancer
Studies Prostatic Neoplasm
10 reported clinical trials
21 drugs studied
Daruka Mahadevan, MD, PhDMays Cancer Center3 years of reported clinical research
Studies Solid Tumors
Studies Cancer
10 reported clinical trials
12 drugs studied
Andrew Brenner, MD, PhDUniversity of Texas Health Science Center at San Antonio6 years of reported clinical research
Studies Glioblastoma
Studies Gliosarcoma
9 reported clinical trials
19 drugs studied
Clinical Trials running at Cancer Therapy and Research Center
Glioblastoma
Cancer
Solid Tumors
Non-Small Cell Lung Cancer
Lymphoma
Lung Cancer
Minimal Residual Disease
Prostatic Neoplasm
Prostate Cancer
Metastatic Tumor
Imipramine + Lomustine
for Glioblastoma
This trial is testing both surgical and non-surgical treatments to see how well they work for patients who need these types of interventions.
Recruiting1 award Phase 210 criteria
BPM31510 + Vitamin K1
for Glioblastoma
This is a single-arm, non-randomized, open-label Phase 2 therapeutic study that will assess the effects of adding BPM31510 onto a conventional treatment framework of RT and concurrent TMZ chemotherapy for subjects with newly diagnosed glioblastoma.
Recruiting1 award Phase 29 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Cancer Therapy and Research Center?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.